• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种双头甘氨酰-脯氨酰-精氨酰-脯氨酸配体模拟纤维蛋白E结构域的功能,以促进因子XIIIa介导的γ链的端到端交联。

A double-headed Gly-Pro-Arg-Pro ligand mimics the functions of the E domain of fibrin for promoting the end-to-end crosslinking of gamma chains by factor XIIIa.

作者信息

Lorand L, Parameswaran K N, Murthy S N

机构信息

Department of Cell and Molecular Biology, Northwestern University Medical School, Chicago, IL 60611, USA.

出版信息

Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):537-41. doi: 10.1073/pnas.95.2.537.

DOI:10.1073/pnas.95.2.537
PMID:9435227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC18455/
Abstract

The E domain of fibrinogen represents the central region of the protein that, after the removal of fibrinopeptides from the N-termini of its alpha chains by thrombin, orders the noncovalent assembly of fibrin units into a half-staggered array. This structural organization is accomplished purely through noncovalent binding between the E domain of one molecule and the distal D domains of two others. The process of assembly has a physiologically important up-regulatory effect on the next enzymatic phase of blood coagulation, which is the factor XIIIa-catalyzed end-to-end ligation of the gamma chains at the D domains of the protein. Fibrin assembly, as well as the acceleration of the factor XIIIa reaction, could be prevented by Gly-Pro-Arg-Pro, a homologue of the natural sequence of amino acids at the N termini of alpha chains in the E domain. We have now succeeded with a simple double-headed ligand, bis(Gly-Pro-Arg-Pro-amido)polyethylene glycol, in fully replacing the regulatory functions of the large E domains of the native protein.

摘要

纤维蛋白原的E结构域代表蛋白质的中心区域,在凝血酶从其α链的N端去除纤维蛋白肽后,它将纤维蛋白单元非共价组装成半交错排列。这种结构组织完全通过一个分子的E结构域与另外两个分子的远端D结构域之间的非共价结合来实现。组装过程对血液凝固的下一个酶促阶段具有重要的生理上调作用,即因子XIIIa催化蛋白质D结构域处γ链的端对端连接。纤维蛋白组装以及因子XIIIa反应的加速可被甘氨酸-脯氨酸-精氨酸-脯氨酸阻止,它是E结构域中α链N端天然氨基酸序列的同系物。我们现在已经成功地用一种简单的双头配体双(甘氨酸-脯氨酸-精氨酸-脯氨酸-酰胺基)聚乙二醇完全取代了天然蛋白质大E结构域的调节功能。

相似文献

1
A double-headed Gly-Pro-Arg-Pro ligand mimics the functions of the E domain of fibrin for promoting the end-to-end crosslinking of gamma chains by factor XIIIa.一种双头甘氨酰-脯氨酰-精氨酰-脯氨酸配体模拟纤维蛋白E结构域的功能,以促进因子XIIIa介导的γ链的端到端交联。
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):537-41. doi: 10.1073/pnas.95.2.537.
2
Contact with the N termini in the central E domain enhances the reactivities of the distal D domains of fibrin to factor XIIIa.与中央E结构域中的N末端接触可增强纤维蛋白远端D结构域对因子XIIIa的反应性。
J Biol Chem. 1995 Sep 15;270(37):21827-32. doi: 10.1074/jbc.270.37.21827.
3
Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.甘氨酰-脯氨酰-精氨酰-脯氨酸修饰纤维蛋白原α链和γ链中的谷氨酰胺残基:抑制转谷氨酰胺酶交联。
Biochim Biophys Acta. 1986 Aug 15;872(3):261-8. doi: 10.1016/0167-4838(86)90279-7.
4
The effect of fibrin polymers on thrombin-catalyzed plasma factor XIIIa formation.纤维蛋白聚合物对凝血酶催化血浆因子XIIIa形成的影响。
Blood. 1985 Aug;66(2):466-9.
5
The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).纤维蛋白原D结构域分子间缔合位点在纤维蛋白和纤维蛋白原东京II(γ275精氨酸→半胱氨酸)聚合中的作用
J Clin Invest. 1995 Aug;96(2):1053-8. doi: 10.1172/JCI118091.
6
Immunoelectrophoretic characterizations of the cross-linking of fibrinogen and fibrin by factor XIIIa and tissue transglutaminase. Identification of a rapid mode of hybrid alpha-/gamma-chain cross-linking that is promoted by the gamma-chain cross-linking.因子XIIIa和组织转谷氨酰胺酶介导的纤维蛋白原与纤维蛋白交联的免疫电泳特征。γ链交联促进的α/γ链快速杂交交联模式的鉴定。
J Biol Chem. 1991 Apr 5;266(10):6429-37.
7
The complementary aggregation sites of fibrin investigated through examination of polymers of fibrinogen with fragment E.通过对纤维蛋白原与E片段聚合物的检测来研究纤维蛋白的互补聚集位点。
Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1438-42. doi: 10.1073/pnas.95.4.1438.
8
Effects of fibrinogen-binding tetrapeptides on mechanical properties of fine fibrin clots.纤维蛋白原结合四肽对精细纤维蛋白凝块力学性能的影响。
Proc Natl Acad Sci U S A. 1985 Mar;82(5):1410-3. doi: 10.1073/pnas.82.5.1410.
9
A gamma Gly-268 to Glu substitution is responsible for impaired fibrin assembly in a homozygous dysfibrinogen Kurashiki I.γ链第268位甘氨酸替换为谷氨酸导致纯合子库拉西基I型异常纤维蛋白原血症中纤维蛋白组装受损。
Blood. 1996 Jun 1;87(11):4686-94.
10
The covalent structure of factor XIIIa crosslinked fibrinogen fibrils.因子XIIIa交联纤维蛋白原纤维的共价结构。
J Struct Biol. 1995 Jul-Aug;115(1):88-101. doi: 10.1006/jsbi.1995.1033.

引用本文的文献

1
Recent advances in biopolymer-based hemostatic materials.基于生物聚合物的止血材料的最新进展
Regen Biomater. 2022 Sep 21;9:rbac063. doi: 10.1093/rb/rbac063. eCollection 2022.
2
Synthetic Strategies for Engineering Intravenous Hemostats.工程化静脉止血剂的合成策略
Bioconjug Chem. 2015 Jul 15;26(7):1224-36. doi: 10.1021/acs.bioconjchem.5b00070. Epub 2015 Apr 6.
3
Modulation of fibrin matrix properties via knob:hole affinity interactions using peptide-PEG conjugates.通过使用肽-PEG 缀合物的旋钮:孔亲和力相互作用来调节纤维蛋白基质特性。
Biomaterials. 2011 Jul;32(19):4406-14. doi: 10.1016/j.biomaterials.2011.02.050. Epub 2011 Mar 23.
4
Transglutaminase-catalyzed crosslinking of the Aalpha and gamma constituent chains in fibrinogen.转谷氨酰胺酶催化纤维蛋白原中α和γ组成链的交联。
Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):44-8. doi: 10.1073/pnas.97.1.44.
5
The location of the carboxy-terminal region of gamma chains in fibrinogen and fibrin D domains.γ链羧基末端区域在纤维蛋白原和纤维蛋白D结构域中的位置。
Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10511-6. doi: 10.1073/pnas.95.18.10511.
6
The complementary aggregation sites of fibrin investigated through examination of polymers of fibrinogen with fragment E.通过对纤维蛋白原与E片段聚合物的检测来研究纤维蛋白的互补聚集位点。
Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1438-42. doi: 10.1073/pnas.95.4.1438.

本文引用的文献

1
On the Solubility of Fibrin Clots.论纤维蛋白凝块的溶解性
Science. 1948 Sep 10;108(2802):280. doi: 10.1126/science.108.2802.280.
2
'Fibrino-peptide'; new aspects of the fibrinogen-fibrin transformation.“纤维蛋白肽”;纤维蛋白原-纤维蛋白转化的新方面
Nature. 1951 Jun 16;167(4259):992-3. doi: 10.1038/167992a0.
3
Action of thrombin in the clotting of fibrinogen.凝血酶在纤维蛋白原凝血过程中的作用。
Nature. 1951 Feb 10;167(4241):233-4. doi: 10.1038/167233a0.
4
Fibrin clots.纤维蛋白凝块
Nature. 1950 Oct 21;166(4225):694-5. doi: 10.1038/166694a0.
5
A NEW CLASS OF BLOOD COAGULATION INHIBITORS.一类新型血液凝固抑制剂。
Arch Biochem Biophys. 1963 Aug;102:171-9. doi: 10.1016/0003-9861(63)90168-1.
6
The fibrinogen molecule: its size, shape, and mode of polymerization.纤维蛋白原分子:其大小、形状及聚合模式。
J Biophys Biochem Cytol. 1959 Jan 25;5(1):11-6. doi: 10.1083/jcb.5.1.11.
7
Fibrino-peptide.纤维蛋白肽
Biochem J. 1952 Oct;52(2):200-3. doi: 10.1042/bj0520200.
8
The action of thrombin on fibrinogen.凝血酶对纤维蛋白原的作用。
Biochem J. 1952 Oct;52(2):196-9. doi: 10.1042/bj0520196.
9
Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin.人纤维蛋白原片段D及其纤维蛋白交联对应物的晶体结构。
Nature. 1997 Oct 2;389(6650):455-62. doi: 10.1038/38947.
10
The polymerization pocket "a" within the carboxyl-terminal region of the gamma chain of human fibrinogen is adjacent to but independent from the calcium-binding site.人纤维蛋白原γ链羧基末端区域内的聚合口袋“a”与钙结合位点相邻但相互独立。
J Biol Chem. 1997 Sep 19;272(38):23792-8. doi: 10.1074/jbc.272.38.23792.